Shifting emphasis from pharmacogenomics to theragnostics

被引:99
作者
Ozdemir, Vural [1 ]
Williams-Jones, Bryn
Glatt, Stephen J.
Tsuang, Ming T.
Lohr, James B.
Reist, Christopher
机构
[1] So Calif Inst Res & Educ, Biomarker & Clin Pharmacol Unit, VA Long Beach Healthcare Syst, Irvine, CA USA
[2] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA USA
[3] Mental Illness Res Educ & Clin Ctr, Long Beach, CA USA
[4] Mental Illness Res Educ & Clin Ctr, San Diego, CA USA
[5] Mental Illness Res Educ & Clin Ctr, Los Angeles, CA USA
[6] Univ Montreal, Grp Rech Bioeth, Montreal, PQ, Canada
[7] Univ Montreal, Dept Med Sociale & Prevent, Montreal, PQ, Canada
[8] Univ Calif San Diego, Ctr Behav Genom, San Diego, CA 92103 USA
[9] Univ Calif San Diego, Psychopharmacol Res Initiat Ctr Excellence, San Diego, CA 92103 USA
关键词
D O I
10.1038/nbt0806-942
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
What will be the role of theragnostic patents in upstream and downstream biomarker research?
引用
收藏
页码:942 / 947
页数:6
相关论文
共 38 条
[31]   Tailored medicine: Whom will it fit? The ethics of patient and disease stratification [J].
Smart, A ;
Martin, P ;
Parker, M .
BIOETHICS, 2004, 18 (04) :322-343
[32]   Knowledge commons or economic engine - what's a university for? [J].
Williams-Jones, B .
JOURNAL OF MEDICAL ETHICS, 2005, 31 (05) :249-250
[33]   Social contract theory and just decision making: Lessons from genetic testing for the BRCA mutations [J].
Williams-Jones, B ;
Burgess, MM .
KENNEDY INSTITUTE OF ETHICS JOURNAL, 2004, 14 (02) :115-142
[34]   Actor-Network Theory: a tool to support ethical analysis of commercial genetic testing [J].
Williams-Jones, B ;
Graham, JE .
NEW GENETICS AND SOCIETY, 2003, 22 (03) :271-296
[35]  
Williams-Jones Bryn, 2003, Am J Pharmacogenomics, V3, P375, DOI 10.2165/00129785-200303060-00004
[36]  
WILLIAMSJONES B, 2006, ETHICS LAW INTELLECT, P172
[37]  
2003, NATURE, V423, P207
[38]  
2005, WIRED NEWS 0307